Advertisement

Parasacral Transcutaneous Electrical Nerve Stimulation (TENS) in Pediatric Bladder Dysfunction

  • Paul J. Guidos
  • Douglas W. Storm
Chapter

Abstract

Urinary incontinence, constipation, and recurrent urinary tract infections are common problems in children and constitute upwards of 40% of all pediatric urology office visits. Common treatment for these issues includes timed toileting, anticholinergics, management of constipation with dietary measures or medications, pelvic floor physical therapy, biofeedback and, at times, surgical intervention. Most of these children will demonstrate improvement in their bowel and bladder dysfunction and a decrease in the number of urinary tract infections (UTIs) with these interventions. However, in some children, alternative therapies may be indicated. One of these alternative therapies is parasacral transcutaneous electrical nerve stimulation (PTENS). Although the exact mechanism of action of PTENS remains elusive, multiple studies have shown this to be a successful treatment, which can be used in the treatment of bladder overactivity, constipation, dysfunctional voiding, and nocturnal enuresis in children. In this chapter, we review normal bladder neuroanatomy and physiology, PTENS technique and its theorized mechanism of action, as well as the indications, treatment outcomes, and side effects of PTENS in children.

Keywords

Pediatric Parasacral electrical stimulation Bladder dysfunction Urinary urgency Urinary incontinence Voiding dysfunction Constipation Overactive bladder 

Abbreviations

BBD

Bladder and bowel dysfunction

DSD

Detrusor sphincter dyssynergia

DV

Dysfunctional voiding

EMG

Electromyogram

ENS

Electrical nerve stimulation

NMNE

Non-monosymptomatic nocturnal enuresis

OAB

Overactive bladder

PMNE

Primary monosymptomatic nocturnal enuresis

PTENS

Parasacral transcutaneous electrical nerve stimulation

References

  1. 1.
    Wright AJ, Haddad M. Electroneurostimulation for the management of bladder bowel dysfunction in childhood. Eur J Paediatr Neurol. 2017;21(1):67–74.CrossRefGoogle Scholar
  2. 2.
    Hoebeke P, Van Laecke E, Everaert K, Renson C, De Paepe H, Raes A, et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol. 2001;166:2416–9.CrossRefGoogle Scholar
  3. 3.
    Bower WF, Moore KH, Adams RD. A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol. 2001;166:2420–2.CrossRefGoogle Scholar
  4. 4.
    Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. J Urol. 2014;191:1863–5.CrossRefGoogle Scholar
  5. 5.
    Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol. 1998;160:1019–22.CrossRefGoogle Scholar
  6. 6.
    Naseer SR, Stenhardt GF. New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation. J Urol. 1997;158:566–8.CrossRefGoogle Scholar
  7. 7.
    Chase J, Austin P, Hoebeke P, McKenna P. The management of dysfunctional voiding in children: a report from the standardisation committee of the International Children’s Continence Society. J Urol. 2010;183(4):1296–302.CrossRefGoogle Scholar
  8. 8.
    Barroso U Jr, Viterbo W, Bittencourt J, Farias T, Lordelo P. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children. J Urol. 2013;190(2):673–7.CrossRefGoogle Scholar
  9. 9.
    Clemens JQ. Basic bladder neurophysiology. Urol Clin North Am. 2010;37(4):487–94.CrossRefGoogle Scholar
  10. 10.
    Kumsar S, Keskin U, Akay A, Bilgilisoy UT, Erdem SR, Peskircioglu CL, et al. Effects of sacral neuromodulation on isolated urinary bladder function in a rat model of spinal cord injury. Neuromodulation. 2015;18(1):67e74.CrossRefGoogle Scholar
  11. 11.
    Bower WF, Moore KH, Adams RD, Shepherd R. A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. J Urol. 1998;160:2133–6.CrossRefGoogle Scholar
  12. 12.
    Plevnik S, Vodušek DB, Vrtačnik P, Janež J. Optimization of pulse duration for electrical stimulation in treatment of urinary incontinence. World J Urol. 1986;4:22–3.CrossRefGoogle Scholar
  13. 13.
    Malm-Buatsi E, Nepple KG, Boyt MA, Austin JC, Cooper CS. Efficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapy. Urology. 2007;70(5):980–3.CrossRefGoogle Scholar
  14. 14.
    Barroso U Jr, Lordêlo P, Lopes AA, Andrade J, Macedo A Jr, Ortiz V. Nonpharmacological treatment of lower urinary tract dysfunction using biofeedback and transcutaneous electrical stimulation: a pilot study. BJU Int. 2006;98(1):166–71.CrossRefGoogle Scholar
  15. 15.
    Tugtepe H, Thomas DT, Ergun R, Kalyoncu A, Kaynak A, Kastarli C, et al. The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback. J Pediatr Urol. 2015;11(3):137.e1–5.CrossRefGoogle Scholar
  16. 16.
    Lordêlo P, Teles A, Veiga ML, et al. Transcutaneous electrical nerve stimulation in children with overactive bladders: a randomized clinical trial. J Urol. 2010;184:683–9.CrossRefGoogle Scholar
  17. 17.
    Lordêlo P, Soares PVL, Maciel I, Macedo A, Barroso U. Prospective study of transcutaneous parasacral electrical stimulation for overactive bladder in children: long-term results. J Urol. 2009;182(6):2900–4.CrossRefGoogle Scholar
  18. 18.
    Hagstroem S, Mahler B, Madsen B, Djurhuus JC, Rittig S. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence. J Urol. 2009;182(4 Suppl):2072–8.CrossRefGoogle Scholar
  19. 19.
    Veiga ML, Queiroz AP, Carvalho MC, Braga AANM, Sousa AS, Barroso U Jr. Parasacral transcutaneous electrical stimulation for overactive bladder in children: an assessment per session. J Pediatr Urol. 2016;12(5):293.e1–5.CrossRefGoogle Scholar
  20. 20.
    Kilic N, Balkan E, Akgoz S, Sen N, Dogruyol H. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability. Int J Urol. 2006;13(2):105–8.  https://doi.org/10.1111/j.1442-2042.2006.01240.x.CrossRefPubMedGoogle Scholar
  21. 21.
    Reinberg Y, Crocker J, Wolpert J, Vandersteen D. Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. J Urol. 2003;169(1):317–9.CrossRefGoogle Scholar
  22. 22.
    Chapple CR, Yamanishi T, Chess-Williams R. Muscarinic receptor subtypes and management of the overactive bladder. Urology. 2002;60:82–9.CrossRefGoogle Scholar
  23. 23.
    Sillén U, Arwidsson C, Doroszkiewicz M, Antonsson H, Jansson I, Stålklint M, et al. Effects of transcutaneous neuromodulation (TENS) on overactive bladder symptoms in children: a randomized controlled trial. J Pediatr Urol. 2014;10(6):1100–5.CrossRefGoogle Scholar
  24. 24.
    Quintiliano F, Veiga ML, Moraes M, Cunha C, de Oliveira LF, Lordelo P, et al. Transcutaneous parasacral electrical stimulation vs oxybutynin for the treatment of overactive bladder in children: a randomized clinical trial. J Urol. 2015;193(5 Suppl):1749–53.CrossRefGoogle Scholar
  25. 25.
    Borch L, Rittig S, Kamperis K, Mahler B, Djurhuus JC, Hagstroem S. No immediate effect on urodynamic parameters during transcutaneous electrical nerve stimulation (TENS) in children with overactive bladder and daytime incontinence—a randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2017;36(7):1788–95.  https://doi.org/10.1002/nau.23179.CrossRefPubMedGoogle Scholar
  26. 26.
    Barroso U Jr, Carvalho MT, Veiga ML, Moraes MM, Cunha CC, Lordêlo P, et al. Urodynamic outcome of parasacral transcutaneous electrical neural stimulation for overactive bladder in children. Int Braz J Urol. 2015;41(4):739–43.  https://doi.org/10.1590/S1677-5538.IBJU.2014.0303.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Houts AC, Berman JS, Abramson H. Effectiveness of psychological and pharmacological treatments for nocturnal enuresis. J Consult Clin Psychol. 1994;62(4):737–45. http://dx.doi.org.proxy.lib.uiowa.edu/10.1037/0022-006X.62.4.737.CrossRefGoogle Scholar
  28. 28.
    Lordêlo P, Benevides I, Kerner EG, Teles A, Lordêlo M, Barroso Jr U. Treatment of non-monosymptomatic nocturnal enuresis by transcutaneous parasacral electrical nerve stimulation. J Pediatr Urol. 2010;6(5):486–9.CrossRefGoogle Scholar
  29. 29.
    Fajardo L, Oliveria D, Iliada L, de Figueiredo AA, de Bessa Junior J, Netto JMB, et al. Transcutaneous parasacral electrical neural stimulation in children with primary monosymptomatic enuresis: a prospective randomized clinical trial. J Urol. 2013;190(4):1359–63.CrossRefGoogle Scholar
  30. 30.
    Moeller Joensson I, Hagstroem S, Siggaard C, Bower W, Djurhuus JC, Krogh K. Transcutaneous electrical nerve stimulation increases rectal activity in children. J Pediatr Gastroenterol Nutr. 2015;61(1):80–4.PubMedGoogle Scholar
  31. 31.
    Chase J, Robertson VJ, Southwell B, Hutson J, Gibb S. Pilot study using transcutaneous electrical stimulation (interferential current) to treat chronic treatment-resistant constipation and soiling in children. J Gastroenterol Hepatol. 2005;20(7):1054–61.CrossRefGoogle Scholar
  32. 32.
    Clarke MCC, Chase JW, Gibb S, Robertson VJ, Catto-Smith A, Hutson J, et al. Decreased colonic transit time after transcutaneous interferential electrical stimulation in children with slow transit constipation. J Pediatr Surg. 2009;44(2):408–12.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of UrologyUniversity of Iowa Hospitals and ClinicsIowa CityUSA

Personalised recommendations